MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-PB-20-0025613
Ankran Biotech Private Limited
Ankran Biotech Private Limited - pharma in Mohali, Punjab, India. FY 2026 financials & compliance.
Revenue · FY 2021
₹8.91 Cr
▲ 262% YoY
Net profit · FY 2021
₹91,370
Net margin 0.1%
EBITDA · FY 2021
₹9.98 Lakh
EBITDA margin 1.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹50,000
Issued & subscribed
Open charges
₹40 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About Ankran Biotech Private Limited
Data last updated:
Ankran Biotech Private Limited is a private limited company based in Mohali, Punjab, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U51502PB2016PTC040130. Its GSTIN is 03AAOCA2053L1ZQ (Punjab).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹50,000. It is led by directors Anjali and Parminder Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at He – 209 Phase – 5 Sas Nagar(Mohali), Punjab, India – 160059.
As per the financials filed for FY 2021, the company reported a revenue of ₹8.91 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹91,370 (net margin 0.1%) and EBITDA of ₹9.98 Lakh (EBITDA margin 1.1%). Revenue has grown at a compounded annual rate (CAGR) of 108% over three years.
As per MCA filings, the company has open charges of ₹40 Lakh on record. Court records list 4 cases involving the company, including 4 filed against it.
Ankran Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-20-0025613). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51502PB2016PTC040130
Registration Number 040130
Incorporation Date 01 March 2016
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-PB-20-0025613
Key People
Anjali Director Parminder Singh Director Recognitions & Rankings of Ankran Biotech
Contact details
Ankran Biotech Private Limited's registered office is in Mohali, Punjab. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHe – 209 Phase – 5 Sas Nagar(Mohali), Punjab, India – 160059
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ankran Biotech Private Limited, buy the company report.
Comprehensive company report
Ankran Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Ankran Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ankran Biotech Private Limited, buy the company report.
Financials of Ankran Biotech Private Limited
FY 2025 filings availableAnkran Biotech Private Limited reported revenue of ₹8.91 Cr (up 262% YoY) for FY 2021.
Revenue · FY 2021
₹8.91 Cr ▲ 262%
Net profit · FY 2021
₹91,370 margin 0.1%
EBITDA · FY 2021
₹9.98 Lakh margin 1.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 262%
3 years · compounded
▲ 108%
EBITDA CAGR growth
1 year
▼ 48%
3 years · compounded
▲ 34%
Revenue has grown at a compounded annual rate (CAGR) of 108% over three years, including 262% growth in the latest year. EBITDA fell 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹8.91 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.98 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹91,370 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ankran Biotech Private Limited, buy the company report.
Board of directors of Ankran Biotech Private Limited
Ankran Biotech has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anjali Also directs: Vexxon Overseas Limited, Amkon Pharmaceuticals Private Limited | Director | 02 Aug 2018 | 8 Years 2 Months | Current |
| Parminder Singh Also directs: Vexxon Overseas Limited, Amkon Pharmaceuticals Private Limited | Director | 01 Mar 2016 | 10 Years 7 Months | Current |
Auditor
Ankran Biotech Private Limited is audited by RAJPAL & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJPAL & ASSOCIATES | FY 2021 | 030666N |
Shareholding
The shareholding of Ankran Biotech Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Ankran Biotech Private Limited, buy the company report.
Charges & borrowings
Open charges
₹40 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Jan 2018 | 100161055 | City Union Bank Limited | ₹40 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Ankran Biotech Private Limited has 4 court cases on record: 4 filed against it. All cases are disposed.
Total cases
4
Filed against the company
4
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by Jips Pharmaceuticals Pvt Ltd | Disposed |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed against the company by M/S Arvincare | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by an individual | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by M/S D M Pharma | Disposed |
To see the full case history of Ankran Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ankran Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ankran Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAOCA2053L1ZQ | Punjab | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ankran Biotech Private Limited, buy the company report.
Recent activity
Ankran Biotech Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Anjali ceased to be Additional Director on 29 Sep 2018.
AGM
Ankran Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ankran Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Ceased
Anjali ceased to be Additional Director.
Appointed
Anjali was appointed as Director.
Ceased
Rajwant Singh ceased to be Director.
Charges
A charge with City Union Bank Limited amounted to Rs. 40.00 Lakh with Charge ID 100161055 was registered on 02 Jan 2018.
Appointed
Parminder Singh was appointed as Director.
Incorporation
01 Mar 2016
Ankran Biotech Private Limited was registered on 01 Mar 2016 with Roc Chandigarh & aged 10 years 7 months as per MCA records.
Frequently asked questions
Ankran Biotech is an active private limited company based in Mohali, Punjab, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 March 2016 (10+ years old) and is registered under CIN U51502PB2016PTC040130.
Ankran Biotech has 2 current directors:
- Anjali - Director
- Parminder Singh - Director
The latest financial statements of Ankran Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Ankran Biotech is 03AAOCA2053L1ZQ, registered in Punjab.
The CIN (Corporate Identification Number) of Ankran Biotech is U51502PB2016PTC040130. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ankran Biotech has 4 court cases on record: 4 filed against it.
Ankran Biotech was incorporated on 01 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Chandigarh.
Anjali ceased to be Additional Director on 29 Sep 2018. Anjali was appointed as Director on 02 Aug 2018. Rajwant Singh ceased to be Director on 04 Jul 2018. Ankran Biotech has 4 board changes on record in total.
Yes, Ankran Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-PB-20-0025613).
The registered office of Ankran Biotech is at He – 209 Phase – 5 Sas NagarMohali, Punjab, India – 160059.